Issue Information – Table of Contents
In memoriam
Systemic mastocytosis
Long‐term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment‐naïve patients with Gaucher disease
Enzyme replacement therapy with taliglucerase alfa
Somatic, hematologic phenotype, long‐term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Association of Pediatric Hematology–Oncology)
Autologous stem cell transplantation in first complete remission may not extend progression‐free survival in patients with peripheral T cell lymphomas
Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis
Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients
Early mortality in multiple myeloma
Retrospective study of rFVIIa, 4‐factor PCC, and a rFVIIa and 3‐factor PCC combination in improving bleeding outcomes in the warfarin and non‐warfarin patient
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN‐associated myelofibrosis
Should any genetic defect affecting α‐granules in platelets be classified as gray platelet syndrome?
Multiple myeloma
Hemoglobin St Mary's
Case series and literature review of skeletal tumors and their incidence in the Gaucher disease population
Monitoring disease burden in chronic myeloid leukemia
“Hairy” cells in acute promyelocytic leukemia
Spontaneous complete resolution of pneumomediastinum and pneumatosis intestinalis caused by acute GVHD
Correction of refractory thrombocytopenia and anemia following withdrawal of extended release niacin
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia uniformly defined as primary by a diagnostic work‐up
Iron restriction is an important treatment of hemoglobin SC disease
The different prognostic impact of type‐1 or type‐1 like and type‐2 or type‐2 like CALR mutations in patients with primary myelofibrosis
Benign chronic immune thrombocytopenic purpura in adult males